Evidence map›Paper›PMID 33543321›Full record

ArticleMikrochimica acta2021

3D-printed microfluidics integrated with optical nanostructured porous aptasensors for protein detection.

Sofia Arshavsky-Graham, Anton Enders, Shanny Ackerman, Janina Bahnemann, Ester Segal

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Aptasensors versus immunosensors-Which will prevail?Engineering in life sciences · 2022
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sofia Arshavsky-GrahamDepartment of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa, Israel.
Anton EndersInstitute of Technical Chemistry, Leibniz University Hannover, Hanover, Germany.
Shanny AckermanDepartment of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa, Israel.
Janina BahnemannInstitute of Technical Chemistry, Leibniz University Hannover, Hanover, Germany. jbahnemann@iftc.uni-hannover.de.ORCID 0000-0002-7008-1673
Ester SegalDepartment of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa, Israel. esegal@technion.ac.il.
Leibniz University Hannover · DETechnion – Israel Institute of Technology · IL

Funding

Deutsche Forschungsgemeinschaft 346772917Deutsche Forschungsgemeinschaft SCHE 279/32-1
6 · The paper itself

Abstract

Microfluidic integration of biosensors enables improved biosensing performance and sophisticated lab-on-a-chip platform design for numerous applications. While soft lithography and polydimethylsiloxane (PDMS)-based microfluidics are still considered the gold standard, 3D-printing has emerged as a promising fabrication alternative for microfluidic systems. Herein, a 3D-printed polyacrylate-based microfluidic platform is integrated for the first time with a label-free porous silicon (PSi)-based optical aptasensor via a facile bonding method. The latter utilizes a UV-curable adhesive as an intermediate layer, while preserving the delicate nanostructure of the porous regions within the microchannels. As a proof-of-concept, a generic model aptasensor for label-free detection of his-tagged proteins is constructed, characterized, and compared to non-microfluidic and PDMS-based microfluidic setups. Detection of the target protein is carried out by real-time monitoring reflectivity changes of the PSi, induced by the target binding to the immobilized aptamers within the porous nanostructure. The microfluidic integrated aptasensor has been successfully used for detection of a model target protein, in the range 0.25 to 18 μM, with a good selectivity and an improved limit of detection, when compared to a non-microfluidic biosensing platform (0.04 μM vs. 2.7 μM, respectively). Furthermore, a superior performance of the 3D-printed microfluidic aptasensor is obtained, compared to a conventional PDMS-based microfluidic platform with similar dimensions.

Indexed as

Acrylic ResinsAptamers, NucleotideBiosensing TechniquesGlycoside HydrolasesImmobilized Nucleic AcidsLab-On-A-Chip DevicesLimit of DetectionMicrofluidic Analytical TechniquesPorosityPrinting, Three-DimensionalProof of Concept StudySiliconAcrylic ResinsAptamers, Nucleotidecarbopol 940Glycoside HydrolasesImmobilized Nucleic AcidsSilicon3D-printingBiosensorMicrofluidicsPDMSPolyacrylatePorous silicon

Identifiers

PMID33543321
PMCPMC7862519
OpenAlexW3128254802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.